MedPath

Randomized Controlled Trial of Doxycycline to Prevent Acquisition of Mycoplasma Pneumoniae in an Outbreak Setting

Not Applicable
Completed
Conditions
Mycoplasma Pneumoniae
Registration Number
NCT00207584
Lead Sponsor
Centers for Disease Control and Prevention
Brief Summary

This study was designed to determine whether taking daily doxycycline during an outbreak of Mycoplasma pneumoniae could prevent a person from getting infected and interrupt ongoing disease transmission during an outbreak. Doxycycline is a treatment for Mycoplasma pneumoniae, but it is not certain that the drug could prevent disease if used prophylactically.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Working at hospital facility where outbreak of Mycoplasma pneumoniae occured
Exclusion Criteria
  • Pregnant, on antiseizure medications, allergic to macrolide antibiotics

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath